Valuation : EMVision Medical Devices Ltd

Market Cap 155M 111M 95.97M 89.98M 82.14M 155M 10.64B 1.07B 417M 5.37B 418M 409M 17.82B P/E 2027 *
-14.8x
P/E 2028 * -12.8x
Enterprise Value 155M 111M 95.97M 89.98M 82.14M 155M 10.64B 1.07B 417M 5.37B 418M 409M 17.82B EV / Sales 2027 *
31x
EV / Sales 2028 * 18.3x
Free-Float
66.78%
Yield 2027 *
-
Yield 2028 * -
1 day-3.19%
1 week-7.73%
Current month+4.70%
1 month+7.74%
3 months-2.91%
6 months-5.38%
Current year-6.18%
1 week 1.64
Extreme 1.64
1.81
1 month 1.5
Extreme 1.5
1.86
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.44
Extreme 1.445
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap.
23/4/26 Buy

Director

10,000 0.0108%
2/1/26 Expiration

Chairman

300,000 0.3228%
18/11/25 Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-3.19%-7.73%-16.50%-1.76% 111M
-1.35%-1.13%+26.27%+12.02% 230B
+0.18%-1.27%+4.98%-18.16% 152B
+1.51%-1.64%-21.28%+20.04% 132B
+0.36%-7.01%-55.60%-14.34% 67.88B
+0.29%+0.47%+10.90%+15.91% 52B
+0.66%-1.69%-16.47%-14.35% 51.05B
-2.44%-3.25%+22.43%+26.08% 43.38B
-1.56%+0.97%+37.41%+44.08% 40.74B
+1.94%+3.81%-12.45%+46.61% 34.67B
Average -0.36%-1.53%-2.03%+11.61% 80.34B
Weighted average by Cap. -0.14%-1.29%+2.51%+7.85%

Financials

2027 *2028 *
Net sales 5M 3.59M 3.09M 2.9M 2.65M 4.98M 343M 34.39M 13.42M 173M 13.47M 13.18M 574M 8.5M 6.1M 5.26M 4.93M 4.5M 8.47M 583M 58.46M 22.81M 294M 22.9M 22.4M 976M
Net income -12M -8.61M -7.42M -6.96M -6.35M -11.96M -823M -82.53M -32.2M -415M -32.32M -31.62M -1.38B -14.5M -10.4M -8.96M -8.41M -7.67M -14.45M -994M -99.72M -38.91M -502M -39.06M -38.21M -1.66B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
28/08/26 $1.670 -3.19% 38,008
27/08/26 $1.725 0.00% 12,846
26/08/26 $1.725 -4.17% 29,810
25/08/26 $1.800 0.00% 30,075
24/08/26 $1.800 -0.55% 78,133
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.670AUD
Average target price
3.150AUD
Spread / Average Target
+88.62%

Annual profits - Rate of surprise